“Model New Science” – This Biotech Is Getting into Scientific Research With What It Says Is Novel Science No One Else Has – Artelo Biosciences (NASDAQ:ARTL)

Greg Gorgas, President & CEO of Artelo Biosciences ARTL, was not too long ago a visitor on Benzinga’s All-Entry.

Artelo is a clinical-stage pharmaceutical firm devoted to the event and commercialization of proprietary therapeutics that modulate lipid-signaling pathways together with the endocannabinoid system. 

Artelo has a portfolio of broadly relevant product candidates designed to deal with vital unmet wants in a number of illnesses and situations, together with anorexia, most cancers, anxiousness, ache, neuropathy and irritation.

Mr. Gorgas spoke in regards to the modern science that his firm is pushing ahead. 

Study extra right here:

Featured picture by Hal Gatewood on Unsplash.

This put up comprises sponsored promoting content material. This content material is for informational functions solely and isn’t supposed to be investing recommendation.